SCHEMBL14704375

SCHEMBL14704375

CC1(C)C2=C(CCC=C2)c2ccc(-c3ccc(-c4cccs4)s3)cc21

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 1/20 0.36
▸ ALOX5 P09917 1/20 0.34
▸ PTGS1 P23219 1/20 0.34
▸ PTGS2 P35354 1/20 0.34
▸ PGR P06401 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ DPP4 P27487 4/20 0.32
▸ ADORA1 P30542 1/20 0.31
▸ PIM1 P11309 1/20 0.31
▸ PIM3 Q86V86 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ GLA P06280 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ SLC6A11 P48066 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15070069 0.80 PDK2 (0.48) PDK2ALOX5PTGS1PTGS2PGR
SCHEMBL15070070 0.76 PDK2 (0.53) PDK2ALOX5PTGS1PTGS2PGR
SCHEMBL14096692 0.72 PDK2 (0.41) PDK2ALOX5PTGS1PTGS2PGR
SCHEMBL12177759 0.70 PDK2 (0.31) PDK2PGR
SCHEMBL10014418 0.70 PDK2 (0.57) PDK2ALOX5PTGS1PTGS2PGR
SCHEMBL10043787 0.70 KDM4E (0.30) KDM4EALDH1A1LMNAMAPT
SCHEMBL13662365 0.70 — —
SCHEMBL22812708 0.70 MEN1 (0.33) PGRKDM4EALDH1A1LMNAGLA
SCHEMBL19527041 0.69 MEN1 (0.36) ADORA1KDM4EALDH1A1LMNAGLA
SCHEMBL12177808 0.69 MEN1 (0.31) PDK2PGRLMNAMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013022136-A1 METHOD FOR MANUFACTURING PHOTOSENSITIVE INKJET INK FOR AN ELECTRODE CAPABLE OF FORMING AN ULTRAHIGH-DENSITY MICROCIRCUIT PATTERN 주식회사 씨드 (KR) 2013-02-14 — — WO disclosed
Send feedback